Plasma adipokines and body composition in response to modest dietary manipulations in the mouse (Q80305268)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16988074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Plasma adipokines and body composition in response to modest dietary manipulations in the mouse (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16988074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Josef V Silha

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16988074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Hope A Weiler

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16988074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Liam J Murphy

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16988074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16988074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16988074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16988074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16988074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

1320-1329

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16988074%20AND%20SRC:MED&resulttype=core&format=json

Analysis of paradoxical observations on the association between leptin and insulin resistance

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Correlation between serum resistin level and adiposity in obese individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

The hormone resistin links obesity to diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Role of resistin in diet-induced hepatic insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Disruption of adiponectin causes insulin resistance and neointimal formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Hexosamines and nutrient excess induce leptin production and leptin receptor activation in pancreatic islets and clonal beta-cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Low resistin levels in adipose tissues and serum in high-fat fed mice and genetically obese mice: development of an ELISA system for quantification of resistin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of ob/ob mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Role of selective leptin resistance in diet-induced obesity hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Radiommunological measurement of leptin in plasma of obese and diabetic human subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Leptin impairs metabolic actions of insulin in isolated rat adipocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Acute and chronic leptin treatment mediate contrasting effects on signaling, glucose uptake, and GLUT4 translocation in L6-GLUT4myc myotubes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Leptin increases hepatic insulin sensitivity and protein tyrosine phosphatase 1B expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Leptin concentrations and insulin sensitivity in normoglycemic men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Leptin and bone: does the brain control bone biology?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Serum leptin level is a regulator of bone mass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Leptin reduces ovariectomy-induced bone loss in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Lack of independent relationship between plasma adiponectin, leptin levels and bone density in nondiabetic female adolescents.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Adenovirus-mediated high expression of resistin causes dyslipidemia in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Decreased Resistin Expression in Mice with Different Sensitivities to a High-Fat Diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Plasma resistin, leptin and adiponectin levels in non-diabetic and diabetic obese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Reciprocal association between visceral obesity and adiponectin: in healthy premenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Reduced adipose tissue mass and hypoleptinemia in iNOS deficient mice: effect of LPS on plasma leptin and adiponectin concentrations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

The yellow agouti mutation alters some but not all responses to diet and exercise

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Adiponectin and its receptors are expressed in bone-forming cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Adiponectin as a novel determinant of bone mineral density and visceral fat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.150

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.150

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16988074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference